LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 42 filers reported holding LUMOS PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $500,000 | – | 50,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $6,714,000 | 1.63% |
| Investors Financial Group, LLC | 115,260 | $1,901,000 | 1.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,169 | $15,437,000 | 0.45% |
| NEA Management Company, LLC | 526,663 | $8,685,000 | 0.35% |
| Logos Global Management LP | 50,000 | $825,000 | 0.16% |
| Wealth Advisors of Iowa, LLC | 11,760 | $194,000 | 0.15% |
| Blackstone Inc. | 468,145 | $7,720,000 | 0.03% |
| Jefferies Group LLC | 120,651 | $1,990,000 | 0.02% |
| Texas Yale Capital Corp. | 15,000 | $247,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,043 | $199,000 | 0.00% |